Core Scientific Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-35.41	-246.49	-2,146.32	47.31	-22.68
Depreciation & Amortization	105.92	96.45	226.09	33.36	9.4
Share-Based Compensation	45.56	58.89	182.89	38.94	3.04
Other Operating Activities	-48.73	156.26	1,943	-176.35	-24
Operating Cash Flow	67.35	65.11	205.19	-56.74	-23.77
Operating Cash Flow Growth	-70.56%	-68.27%	-	-	-
Capital Expenditures	-47.35	-16.99	-601.66	0.7	-1.57
Acquisitions	14	14	10.85	-424.49	-13.67
Other Investing Activities	0.25	-	0.03	-0.06	0.09
Investing Cash Flow	-33.1	-3	-590.78	-423.84	-15.14
Share Issuance / Repurchase	55.01	0	188.41	0.51	2.64
Debt Issued / Paid	-40.88	-44.65	117.74	613.7	38.08
Other Financing Activities	-3.39	-	-	-10.68	-
Financing Cash Flow	10.74	-44.65	306.15	603.53	40.72
Net Cash Flow	44.98	17.47	-79.44	122.96	1.81
Free Cash Flow	20	48.12	-396.47	-56.03	-25.33
Free Cash Flow Margin	3.56%	9.58%	-61.92%	-10.29%	-42.00%
Free Cash Flow Per Share	0.09	0.13	-1.16	-0.27	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).